Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of PS-341 in Combination With Topotecan in Advanced Solid Tumor Malignancies

NCT00541359 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00541359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00541359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of PS-341 in Combination With Topotecan in Advanced Solid Tumor Malignancies
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2004
Completion date
June 30, 2011
Enrollment
54 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific